Literature DB >> 24085293

Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death.

Emma Linderoth1, Giulia Pilia, Nupam P Mahajan, Ingvar Ferby.   

Abstract

TNF-related apoptosis-inducing ligand (TRAIL) holds promise for treatment of cancer due to its ability to selectively kill cancer cells while sparing normal cells. Ligand-induced translocation of TRAIL receptors (TRAIL-R) 1 and 2 (also called DR4 and DR5, respectively) into lipid raft membrane microdomains is required for TRAIL-induced cell death by facilitating receptor clustering and formation of the death-inducing signaling complex, yet the underlying regulatory mechanisms remain largely unknown. We show here that the non-receptor tyrosine kinase Ack1, previously implicated in the spatiotemporal regulation of the EGF receptor, is required for TRAIL-induced cell death in multiple epithelial cell lines. TRAIL triggered a transient up-regulation of Ack1 and its recruitment to lipid rafts along with TRAIL-R1/2. siRNA-mediated depletion of Ack1 disrupted TRAIL-induced accumulation of TRAIL-R1/2 in lipid rafts and efficient recruitment of caspase-8 to the death-inducing signaling complex. Pharmacological inhibition of Ack1 did not affect TRAIL-induced cell death, indicating that Ack1 acts in a kinase-independent manner to promote TRAIL-R1/2 accumulation in lipid rafts. These findings identify Ack1 as an essential player in the spatial regulation of TRAIL-R1/2.

Entities:  

Keywords:  Apoptosis; Cancer; Cell Signaling; Lipid Rafts; TRAIL; Tyrosine-Protein Kinase (Tyrosine Kinase)

Mesh:

Substances:

Year:  2013        PMID: 24085293      PMCID: PMC3829143          DOI: 10.1074/jbc.M113.481507

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors.

Authors:  M Teo; L Tan; L Lim; E Manser
Journal:  J Biol Chem       Date:  2001-02-27       Impact factor: 5.157

2.  Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1.

Authors:  W Yang; Q Lin; J L Guan; R A Cerione
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

3.  Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain.

Authors:  W Yang; R A Cerione
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

4.  Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.

Authors:  K M Eisenmann; J B McCarthy; M A Simpson; P J Keely; J L Guan; K Tachibana; L Lim; E Manser; L T Furcht; J Iida
Journal:  Nat Cell Biol       Date:  1999-12       Impact factor: 28.824

5.  A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42.

Authors:  E Manser; T Leung; H Salihuddin; L Tan; L Lim
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

6.  Glucocorticoid-induced suppression of β-cell proliferation is mediated by Mig6.

Authors:  E Scott Colvin; Hong-Yun Ma; Yi-Chun Chen; Angelina M Hernandez; Patrick T Fueger
Journal:  Endocrinology       Date:  2013-02-05       Impact factor: 4.736

7.  Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

Authors:  H Li; H Zhu; C J Xu; J Yuan
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

8.  Tyrosine phosphorylation of ACK in response to temperature shift-down, hyperosmotic shock, and epidermal growth factor stimulation.

Authors:  T Satoh; J Kato; K Nishida; Y Kaziro
Journal:  FEBS Lett       Date:  1996-05-20       Impact factor: 4.124

9.  Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.

Authors:  Jagan R Muppidi; Richard M Siegel
Journal:  Nat Immunol       Date:  2004-01-25       Impact factor: 25.606

10.  Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

Authors:  Zhaoyu Jin; E Robert McDonald; David T Dicker; Wafik S El-Deiry
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

View more
  4 in total

1.  Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cells.

Authors:  Tomoya Fukuoka; Kenta Moriwaki; Shinji Takamatsu; Jumpei Kondo; Miki Tanaka-Okamoto; Azusa Tomioka; Manami Semba; Sachiko Komazawa-Sakon; Yoshihiro Kamada; Hiroyuki Kaji; Yasuhide Miyamoto; Masahiro Inoue; Kazuhiko Bessho; Yoko Miyoshi; Keiichi Ozono; Hiroyasu Nakano; Eiji Miyoshi
Journal:  Oncogene       Date:  2022-08-15       Impact factor: 8.756

Review 2.  Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells.

Authors:  Sundas Fayyaz; Ilhan Yaylim; Saime Turan; Sobia Kanwal; Ammad Ahmad Farooqi
Journal:  Mol Biol Rep       Date:  2014-07-19       Impact factor: 2.316

3.  Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.

Authors:  Maria Del Mar Masdeu; Beatriz G Armendáriz; Anna La Torre; Eduardo Soriano; Ferran Burgaya; Jesús Mariano Ureña
Journal:  Oncotarget       Date:  2017-09-15

4.  Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.

Authors:  Minami Kumazaki; Haruka Shinohara; Kohei Taniguchi; Hiroshi Ueda; Mayuko Nishi; Akihide Ryo; Yukihiro Akao
Journal:  Oncotarget       Date:  2015-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.